Previous close | 224.98 |
Open | 224.83 |
Bid | 226.75 x 800 |
Ask | 226.82 x 1200 |
Day's range | 224.32 - 226.97 |
52-week range | 156.72 - 231.86 |
Volume | |
Avg. volume | 1,276,645 |
Market cap | 64.71B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 41.91 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (1.01%) |
Ex-dividend date | 18 Mar 2024 |
1y target est | N/A |
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.